Scientists from leading companies were quizzed by children from Milton Road Primary School as Cambridge Science Centre hosted ...

Armed with some data from our friends at CrunchBase, I broke down the largest US startup funding rounds from January 2025. I have included some additional information such as industry, company ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

Illumina is raising the curtain on its upcoming entry into spatial transcriptomics, with tech designed to help researchers ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

The Broad Institute and Illumina today announced their intent to collaborate on a groundbreaking Spatial Flagship Project, ...

Set for release in 2026, the ‘first-of-its-kind’ technology aims to give researchers the ability to analyse more cells in a ...

We recently published a list of Top 10 AI Stocks Buzzing on Latest News. In this article, we are going to take a look at where Illumina, Inc.

Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

BofA lowered the firm’s price target on Illumina (ILMN) to $90 from $110 and keeps an Underperform rating on the shares. Shares have fallen 25% ...

To be successful, health care organizations ... Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...